Drug intelligence / Profile preview

Human C1-esterase inhibitor

Development stage
Approved
Lead developer
Takeda
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous, Subcutaneous, Nebulized
01

Overview

Human C1-esterase inhibitor is a protein that functions as a key down-regulator of the complement and contact activation systems. It can be derived from human plasma or produced recombinantly. It is approved for the treatment of acute attacks and prophylaxis of hereditary angioedema (HAE), a condition caused by C1 inhibitor deficiency or dysfunction. The drug works by inhibiting complement activation, which is implicated in the pathophysiology of HAE and other inflammatory conditions. It is also being investigated for its potential to ameliorate adverse drug reactions related to IVIG infusions, treat acute exacerbations of neuromyelitis optica (NMO), and has shown efficacy in preclinical models for conditions like hemorrhagic shock and immune-mediated hemolytic anemia.

Brand names
RUCONESTCINRYZEHAEGARDABerinert
Other names
C1-esterase inhibitor (human)C1-esterase inhibitor concentrateC-1-esterase inhibitor concentrateC 1-esterase inhibitor concentratePurified human C1-esterase inhibitorPlasma-derived human C1-esterase inhibitor
02

Targets

Factor XIaPLAT (Tissue-type plasminogen activator)C1R (Complement component 1r subcomponent)FXIIa (Coagulation Factor XIIa)C1S (Complement component 1s subcomponent serine protease)MASP2 (Mannan-binding lectin-associated serine protease 2)PLG (Plasminogen)KLKB1 (Plasma kallikrein)

Beyond the preview

Go deeper on Human C1-esterase inhibitor.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human C1-esterase inhibitor.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call